WO2023057953 - 5-MAPB OR 6-APB FOR USE IN DRUG-ASSISTED PSYCHOTHERAPY

National phase entry:
Publication Number WO/2023/057953
Publication Date 13.04.2023
International Application No. PCT/IB2022/059561
International Filing Date 06.10.2022
Title **
[English] 5-MAPB OR 6-APB FOR USE IN DRUG-ASSISTED PSYCHOTHERAPY
[French] 5-MAPB OU 6-APB POUR UNE UTILISATION DANS LA PSYCHOTHÉRAPIE ASSISTÉE PAR MÉDICAMENT
Applicants **
CLEARMIND MEDICINE INC. 20 Raoul Wallenberg Street Building A, 2nd Fl. Tel Aviv, IL
Inventors
GOLAN, Ezekiel 1120 Ironwork Passage Vancouver, British Columbia V6H 3P1, CA
Priority Data
63/253,443   07.10.2021   US
Application details
Total Number of Claims/PCT *
Number of Independent Claims *
Number of Priorities *
Number of Multi-Dependent Claims *
Number of Drawings *
Pages for Publication *
Number of Pages with Drawings *
Pages of Specification *
*
*
International Searching Authority
*
Applicant's Legal Status
*
*
*
*
*
Entry into National Phase under
*
Translation

Recalculate

* The data is based on automatic recognition. Please verify and amend if necessary.

** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.

Quotation for National Phase entry

Country StagesTotal
China Filing1310
EPO Filing, Examination6746
Japan Filing589
South Korea Filing575
USA Filing, Examination2910
MasterCard Visa

Total: 12130

The term for entry into the National Phase has expired. This quotation is for informational purposes only

Abstract[English] The present invention relates to methods of drug-assisted psychotherapy, particularly with methods employing 5-MAPB or 6-APB. The present invention also relates to kits comprising 5-MAPB or 6-APB for use in the treatment of subjects undergoing psychotherapeutic intervention. In particular, methods and kits for drug-assisted psychotherapy with 5-MAPB or 6-APB for a variety of disorders and/or conditions, including PTSD, GAD and relationship distress are provided.[French] La présente invention concerne des méthodes de psychothérapie assistée par médicament, en particulier avec des méthodes utilisant le 5-MAPB ou le 6-APB. La présente invention concerne également des kits comprenant le 5-MAPB ou le 6-APB pour une utilisation dans le traitement de sujets subissant une intervention psychothérapeutique. En particulier, l'invention concerne des méthodes et des kits pour une psychothérapie assistée par médicament avec le 5-MAPB ou le 6-APB pour une variété de troubles et/ou d'affections, notamment le TSPT, le TAG et la détresse relationnelle.
An unhandled error has occurred. Reload 🗙